Literature DB >> 2574118

A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice.

K Kaku1, J McGill, M Province, M A Permutt.   

Abstract

To assess genetic factors determining sensitivity to streptozotocin-induced diabetes in inbred strains of mice, a genetic analysis of streptozotocin-sensitive C57BL/6J and streptozotocin-resistant C3H/HeJ mice was performed. One week after a single dose of streptozotocin (200 mg/kg body weight), differences in plasma glucose concentration were marked between male mice of the C57BL/6J and C3H/HeJ strains (p less than 0.001). To determine the number of genes responsible for the difference, F1 male progeny of a cross between parental strains were produced, and found to be streptozotocin resistant like C3H/HeJ parents. F1 mice were, therefore, backcrossed with streptozotocin-sensitive C57BL/6J mice (Backcross: F1 female female X C57BL/6J male male). The plasma glucoses of backcrossed male mice (n = 41) following streptozotocin treatment appeared to segregate into two populations, half like the C57BL/6J parent, and half like the F1 parent. Statistical analysis of the data revealed that the data fit a model with two distributions better than one with a single distribution, suggesting a single major gene responsible for the difference in streptozotocin susceptibility. This hypothesis was also supported by the observation that streptozotocin sensitivity in 12 recombinant inbred strains of C57BL/6J and C3H/HeJ mice appeared to segregate into two classes. Resistance to streptozotocin induced diabetes in F1 mice suggested that the expression of this gene is recessive, although X-chromosome linked inheritance could not be excluded. Efforts to map the streptozotocin-sensitivity gene revealed lack of right linkage to several loci including the H-2 locus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574118     DOI: 10.1007/bf00274530

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies.

Authors:  A A Like; M C Appel; R M Williams; A A Rossini
Journal:  Lab Invest       Date:  1978-04       Impact factor: 5.662

2.  Statistical considerations for linkage analysis using recombinant inbred strains and backcrosses.

Authors:  J Silver; C E Buckler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Studies of the diabetogenic action of streptozotocin.

Authors:  A Junod; A E Lambert; L Orci; R Pictet; A E Gonet; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

4.  Androgen sensitization of streptozotocin-induced diabetes in mice.

Authors:  N K Maclaren; M Neufeld; J V McLaughlin; G Taylor
Journal:  Diabetes       Date:  1980-09       Impact factor: 9.461

5.  Sex differences in the multiple-dose streptozotocin model of diabetes.

Authors:  A A Rossini; R M Williams; M C Appel; A A Like
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

6.  New diabetogenic streptozocin analogue, 3-O-methyl-2-([(methylnitrosoamino) carbonyl]amino)-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells.

Authors:  J Kawada; K Toide; M Nishida; Y Yoshimura; K Tsujihara
Journal:  Diabetes       Date:  1986-01       Impact factor: 9.461

7.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

8.  Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.

Authors:  U Kiesel; F W Falkenberg; H Kolb
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.

Authors:  T Anderson; P S Schein; M G McMenamin; D A Cooney
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

View more
  3 in total

1.  Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damage.

Authors:  Masih-ul Alam; Julie A Harken; Anna-Maria Knorn; Alisha R Elford; Kip Wigmore; Pamela S Ohashi; Douglas G Millar
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

2.  Congenic mapping and candidate gene analysis for streptozotocin-induced diabetes susceptibility locus on mouse chromosome 11.

Authors:  Tomoki Maegawa; Yuki Miyasaka; Misato Kobayashi; Naru Babaya; Hiroshi Ikegami; Fumihiko Horio; Masahide Takahashi; Tamio Ohno
Journal:  Mamm Genome       Date:  2018-03-09       Impact factor: 2.957

3.  Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes.

Authors:  C Gonzalez; S Cuvellier; C Hue-Beauvais; M Lévi-Strauss
Journal:  Diabetologia       Date:  2003-07-15       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.